Evidence map›Paper›PMID 42191912›Full record

Articlenpj antimicrobials and resistance2026

Prediction of antimicrobial minimum inhibitory concentration from bacterial genomes using a scalable and interpretable machine learning approach.

Alessandro Gerada, Yinzheng Zhong, Nicholas Harper, Anoop Velluva, Nada Reza, Vineet Dubey, Alex Howard, Peter L Green, Steve Paterson, William Hope

Abstract read
In one paragraph

Article in npj antimicrobials and resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alessandro Gerada *Department of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK. alessandro.gerada@liverpool.ac.uk.
Yinzheng Zhong *Department of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Nicholas HarperDepartment of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Anoop VelluvaDepartment of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Nada RezaDepartment of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Vineet DubeyDepartment of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Alex HowardDepartment of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Peter L GreenDepartment of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Steve PatersonInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
William HopeDepartment of Clinical Pharmacology and Therapeutics, Antimicrobial Pharmacodynamics and Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.

Funding

UKRI 2599501Wellcome TrustWellcome Trust 226691/Z/22/Z
6 · The paper itself

Abstract

Although machine learning models can predict antimicrobial susceptibility from bacterial whole genome sequencing (WGS), state-of-the-art approaches are computationally demanding or dependent on knowledge of genetic resistance determinants. Here, we describe an efficient data-driven approach to predicting minimum inhibitory concentration (MIC) by progressively extending and refining predictive genome segments, independent of prior knowledge of resistance determinants. Resultant models had high interpretability - known and potentially novel resistance determinants were captured. Using 762 clinical E. coli strains, 71.6% of predictions were within one dilution of the measured MIC. Models trained with this algorithm generalised better onto external data (F1 score = 0.85) compared with alternative models trained on annotated resistance determinants (F1 = 0.82) or k-mer counts (F1 = 0.74). Computational demands were low (RAM usage 23.6GB vs 38.8GB for k-mer model). These advantages represent an important advance in predicting antimicrobial susceptibility from WGS, with potential applications for clinical diagnostics, drug development, and surveillance.

Identifiers

PMID42191912
PMCPMC13530227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.